Adage Capital Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Adage Capital Partners’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41M	Sell	350,000 -25,000	-7%	-$2.51M	0.06%	330
2026 Q1	$34.6M	Sell	375,000 -92,468	-20%	-$8.7M	0.05%	332
2025 Q4	$36.9M	Sell	467,468 -30,000	-6%	-$2.15M	0.06%	321
2025 Q3	$36.5M	Buy	497,468 +254,468	+105%	+$16.2M	0.06%	308
2025 Q2	$12.4M	Sell	243,000 -102,000	-30%	-$4.54M	0.02%	568
2025 Q1	$15.5M	Buy	345,000 +195,000	+130%	+$9.19M	0.03%	476
2024 Q4	$6.2M	Buy	150,000 +70,000	+88%	+$2.92M	0.01%	692
2024 Q3	$3.12M	Sell	80,000 -80,000	-50%	-$3.19M	0.01%	752
2024 Q2	$5.47M	Hold	160,000	–	–	0.01%	703
2024 Q1	$4.02M	Sell	160,000 -415,000	-72%	-$11.4M	0.01%	720
2023 Q4	$17M	Sell	575,000 -90,000	-14%	-$2.72M	0.04%	468
2023 Q3	$21M	Buy	+665,000	New	+$18.2M	0.05%	381

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adage Capital Partners's MIRM Position: Q2 2026 in Review

Adage Capital Partners reduced its Mirum Pharmaceuticals (MIRM) stake by 6.7% in Q2 2026, selling an estimated $2.51M and leaving 350,000 shares worth $41M. The position accounts for 0.06% of the portfolio, ranked #330.

Adage Capital Partners first reported a position in MIRM in Q3 2023 and has held it in 12 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Adage Capital Partners held 350,000 shares of Mirum Pharmaceuticals worth $41M as of Q2 2026.
Adage Capital Partners sold 25,000 Mirum Pharmaceuticals shares in Q2 2026, an estimated $2.51M.
Mirum Pharmaceuticals made up 0.06% of Adage Capital Partners's portfolio in Q2 2026, its #330 holding.
Adage Capital Partners first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.